HomeQNRX • NASDAQ
Quoin Pharmaceuticals Ltd - ADR
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.96M | 60.97% |
Net income | -3.81M | -63.80% |
Net profit margin | — | — |
Earnings per share | -6.50 | 83.16% |
EBITDA | -3.93M | -61.60% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.55M | -21.36% |
Total assets | 12.96M | -19.65% |
Total liabilities | 7.03M | 0.45% |
Total equity | 5.93M | — |
Shares outstanding | 588.17K | — |
Price to book | 0.82 | — |
Return on assets | -69.03% | — |
Return on capital | -95.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.81M | -63.80% |
Cash from operations | -2.59M | -80.86% |
Cash from investing | 2.77M | 162.03% |
Cash from financing | 22.96K | -99.57% |
Net change in cash | 198.78K | 135.02% |
Free cash flow | -1.49M | -172.12% |
Previous close
$8.29
Day range
$8.20 - $8.52
Year range
$5.05 - $54.95
Market cap
4.90M USD
Avg Volume
355.08K
About
Founded
1986
Website
Employees
4
